4F-MPH

From PsychonautWiki
(Redirected from 4-Fluoromethylphenidate)
Jump to: navigation, search
4F-MPH
4-Fluoromethylphenidate.png
Chemical Nomenclature
Common names 4F-MPH, 4-FMPH
Substitutive name 4-Fluoromethylphenidate
Systematic name methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate <-- Class Membership -->
Class Membership
Psychoactive class Stimulant
Chemical class Phenethylamine
Routes of Administration



Oral
Dosage
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.
DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation.
This dosage and duration information has been sourced from TripSit
Threshold < 5 mg
Light 5 - 10 mg
Common 10 - 15 mg
Strong 15 - 20 mg
Heavy 20 mg +
Duration
Total 4 - 7 hours
Onset 25 - 40 minutes
After effects 5 - 10 hours









Summary sheet: 4F-MPH

4F-MPH (4'-fluoro-methylphenidate) is a stimulant, substituted phenethylamine, piperidine, and close analog of methylphenidate (ritalin). The two substances have very similar pharmacological mechanisms but distinctively different subjective effects as 4F-MPH can be considered significantly more euphoric and recreational in its experience. It also acts as a higher efficiency dopamine reuptake inhibitor than the closely related methylphenidate.[1][2][3][4][5]

4F-MPH has little to no history of human usage prior to its distribution online through research chemical vendors. It was initially developed as a replacement for ethylphenidate which became illegal in the United Kingdom on April 10, 2015 due to a temporary blanket ban. Anecdotal reports suggest that it is considerably more potent with fewer uncomfortable side effects such as anxiety, muscle spasms and compulsive redosing.[6]

Chemistry

Molecule.svg

This chemistry section is incomplete.

You can help by adding to it.

4F-MPH is nearly identical in structure to methylphenidate (ritalin); the difference is that it has a fluorine atom bonded to the phenyl group at the 4 position. Amphetamine analogues containing fluorine, chlorine, bromine and methyl groups are typically stronger than those without.

Pharmacology

4F-MPH acts as a dopamine reuptake inhibitor, meaning it effectively boosts the levels of dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft. This allows dopamine to accumulate within the brain, resulting in stimulating and euphoric effects.

Subjective effects

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.

Physical effects

Cognitive effects

Toxicity and harm potential

The toxicity and long-term health effects of recreational 4F-MPH use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 4F-MPH is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried 4F-MPH suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption.

It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

In terms of its tolerance, 4F-MPH can be used multiple days in a row for extended periods of time, but acute tolerance does exist and builds up gradually over repeated extended use. This results in the user requiring an increase in dosage to achieve the same effects.

4F-MPH has potential for abuse on par with that of amphetamine or MDMA due to its lack of significant tolerance, euphoric effects and action upon dopamine transporters.

Dangerous interactions

Although many drugs are safe on their own, they can become dangerous and even life-threatening when combined with other substances. The list below contains some common potentially dangerous combinations, but may not include all of them. Certain combinations may be safe in low doses of each but still increase the potential risk of death. Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.

Legal issues

Handcuffs-300px.png

This legality section is a stub.

As such, it likely contains incomplete or wrong information. You can help by expanding it.

  • United Kingdom - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.[8]
  • U.S. - 4-Fluromethylphenidate is a Schedule I controlled substance in the state of Alabama.[9]

See also

External links

References

  1. Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/8632426
  2. Biochemical and behavioral characterization of novel methylphenidate analogs (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/11961053
  3. Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/15026075
  4. Quantitative structure-activity relationship studies of threo-methylphenidate analogs (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/20846865
  5. Chemistry, Design, and Structure−Activity Relationship of Cocaine Antagonists | http://pubs.acs.org/doi/abs/10.1021/cr9700538
  6. http://www.bluelight.org/vb/threads/770658-4-Fluoromethylphenidate-(4F-MPH)
  7. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity | http://bja.oxfordjournals.org/content/95/4/434
  8. Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted
  9. Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd. | https://legiscan.com/AL/text/SB333/2014